65,437 trials
Neoplasms · Constipation · Opioid-Related Disorders
Primary: Rescue-free Laxation After Administration of Subcutaneous Methylnaltrexone — 33 percentage of participants
Phenylketonuria
Primary: Change in Attention-Deficit Hyperactivity Disorder Rating Scale-IV (ADHD-RS) / Adult ADHD Self-Report Scale (ASRS) Total Score From Baseline to Week 13 — -4.9; -9.1…
Parkinson's Disease
Primary: AChE PET Neuroimaging — 0.0238; 0.0226 1/min — p=0.0009
Multiple Sclerosis, Relapsing-remitting
Primary: Change in Mean Serum Level of 25-hydroxyvitamin D — 65.9; 82.4 nmol/L — p=0.001
Hepatitis C, Chronic
Primary: Part 1: Rapid Virological Response (RVR) — 73.3; 100.0 Percentage of participants
Smoking
Primary: 7-day Point-prevalence Smoking Abstinence — 12; 7 Number of abstinent participants — p=.262
Leukemia · Lymphoma
Primary: Survival at 1 Year After Transplantation — 10; 6 participants
Infections
Primary: Clinical Response at Study Day 4 in the Modified Intent-to-Treat (MITT) Population — 14; 8; 16; 8 participants
Chronic Urticaria
Primary: Duration of Urticaria Until Remission Since Chronic Urticaria Was Diagnosed. — 18.5; 54; 67.7 percentage of participants
Leukemia · Myelodysplastic Syndrome · Non-Hodgkin's Lymphoma
Primary: Death From GVHD — 4 participants
Multiple Sclerosis
Primary: Change in Patient Visual Analog Scale Score for Pre-injection Anxiety — 1.58; 2.22 cm — p=<.05
Cannabis Dependence
Primary: Feasibility — 1; 1; 1; 2 participants
Muscle Spasticity
Primary: Change From Baseline in Modified Ashworth Scale-Bohannon (MAS-B) Score of Ankle Plantar Flexors Using a 6-Point Scale — 4.1; 4.1; -0.81; -0.61 Scores on a Scale
Postoperative Vomiting
Primary: Postoperative Vomiting — 11; 9; 66; 68 participants — p=0.05
Pancreatic Cancer
Primary: To Compare 60-day ≥Grade 3 Pancreatic Complication Rates (Fistula, Leak, and Abscess) as Defined by the MSKCC Surgical Secondary Events System Between Patients Who…